Harvard Medical School researchers have shown that the plant-derived small molecule huperzine A can reduce neuropathic pain in mice with spinal cord injury. Insero Health has licensed IP covering epilepsy and neuropathic pain and plans to report Phase Ib data this year in treatment-resistant epilepsy.